Paediatric Hemato-Oncology

To provide students with in‑depth knowledge of paediatric oncology. In the study process, special emphasis will be placed on the principles of chemotherapy, its mechanisms of action and the most common complications, especially febrile neutropenia as one of the most frequent and potentially life‑threatening complications after chemotherapy, as well as its timely recognition, emergency management and treatment algorithms. The program will also include knowledge of modern therapeutic options in paediatric haemato-oncology, including targeted therapy, immunotherapy, monoclonal antibodies, cell therapy (for example, CAR‑T therapy) and the principles of personalized treatment, highlighting their importance in improving treatment effectiveness and reducing toxicity.Particular attention will also be paid to central nervous system (CNS) tumours as the most common solid tumours in childhood, their clinical signs, neurological symptoms, diagnostic methods and multimodal treatment (surgery, radiotherapy, chemotherapy). Students will also acquire knowledge about late treatment effects, including cardiotoxicity, endocrine disorders, growth and developmental delay, neurocognitive impairments and the risk of secondary tumours, emphasizing the importance of long‑term follow‑up and multidisciplinary care. The aim of the course is to develop clinical reasoning and the ability to critically evaluate strategies for diagnostics, treatment, complication prevention and long‑term follow‑up in paediatric haemato-oncology, ensuring competent and safe care for paediatric patients.

Basic knowledge of human anatomy, physiology, pathology, immunology, and an introduction to pediatrics.